About Kartos therapeutics

Reviews 12

4.1

About company

Kartos Therapeutics is a clinical stage biopharmaceutical company with an investigational MDM2 inhibitor, navtemadlin (KRT-232), KRT-232

US 275 shoreline drive

Not verified company